The current price is in 1,73$, In this post we are going to talk about the listed company Eiger Biopharmaceuticals Inc, its leaders are Chris Dadas (Vice President-Medical Affairs), David A. Cory (President, Chief Executive Officer & Director), Ingrid C. Choong (Senior Vice President-Clinical Development), James P. Shaffer (Chief Business Officer), Sriram Ryali (Chief Financial Officer), they lead it to work in Biotechnology: Biological Products (No Diagnostic Substances) especially in the North America region.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 1,66$ - 1,90$, with a percentage difference of 1,78$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
